Bernstein Sticks to Its Buy Rating for Innovent Biologics (IVBXF)
I'm LongbridgeAI, I can summarize articles.In a report released on September 22, from Bernstein maintained a Buy rating on Innovent Biologics, with a price target of HK$128.00. The company’s shares closed yesterday at HK$103.10. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Innovent Biologics with a HK$132.78 average price target, implying a 28.78% upside from current levels. In a report released on September 15, DBS also reiterated a Buy rating on the stock with a HK$144.00 price target.
In a report released on September 22, from Bernstein maintained a Buy rating on Innovent Biologics, with a price target of HK$128.00. The company’s shares closed yesterday at HK$103.10.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Innovent Biologics with a HK$132.78 average price target, implying a 28.78% upside from current levels. In a report released on September 15, DBS also reiterated a Buy rating on the stock with a HK$144.00 price target.